MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
648
Unique beneficiaries
—
Total services
2,074
Distinct HCPCS
17
Medicare payment
$46K
PRESCRIBING · PART D · 2024
Total Rx claims
164
Beneficiaries
—
Total drug cost
$24K
Distinct drugs
10
Brand share
8.5%
Top prescribed drugs
Levofloxacin23 claims
Acyclovir21 claims
Temazepam19 claims
Pantoprazole Sodium18 claims
Potassium Chloride18 claims
QUALITY · MIPS · 2024
Final MIPS score
85.1
Quality
67.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.43%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
23
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$1K
Food and Beverage$811
Top paying entities
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$1K
Food and Beverage$811
REFERRAL NETWORK
Where Tracy Martin's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 5 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER | 48 | 237 |
| TARRAND, JEFFREY | 11 | 18 |
| Nicole Brunelle Nurse Practitioner · Houston, TX | 11 | 14 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER | 44 | 209 |
| Beverly Handy Pathology · Houston, TX | 19 | 29 |
| Krina Patel Hematology-Oncology · Houston, TX | 12 | 43 |
| TARRAND, JEFFREY | 11 | 21 |
| Muzaffar Qazilbash Hematopoietic Cell Transplantation and Cellular Therapy · Houston, TX | 11 | 40 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE